BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12210554)

  • 21. Investigation of the potential pharmacokinetic and pharmaco-dynamic drug interaction between AHN 1-055, a potent benztropine analog used for cocaine abuse, and cocaine after dosing in rats using intracerebral microdialysis.
    Raje S; Cornish J; Newman AH; Cao J; Katz JL; Eddington ND
    Biopharm Drug Dispos; 2006 Jul; 27(5):229-40. PubMed ID: 16586462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
    Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
    J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
    Volz TJ; Kim M; Schenk JO
    Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel benztropine [3a-(diphenylmethoxy)tropane] analogs as probes for the dopamine transporter.
    Newman AH; Agoston GE
    Curr Med Chem; 1998 Aug; 5(4):305-19. PubMed ID: 9668197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, molecular modeling, and biological studies of novel piperidine-based analogues of cocaine: evidence of unfavorable interactions proximal to the 3alpha-position of the piperidine ring.
    Petukhov PA; Zhang J; Wang CZ; Ye YP; Johnson KM; Kozikowski AP
    J Med Chem; 2004 Jun; 47(12):3009-18. PubMed ID: 15163183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes.
    Carroll FI; Pawlush N; Kuhar MJ; Pollard GT; Howard JL
    J Med Chem; 2004 Jan; 47(2):296-302. PubMed ID: 14711303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of cis-(6-benzhydrylpiperidin-3-yl)benzylamine analogues with monoamine transporters: structure-activity relationship study of structurally constrained 3,6-disubstituted piperidine analogues of (2,2-diphenylethyl)-[1-(4-fluorobenzyl)piperidin-4-ylmethyl]amine.
    Kolhatkar RB; Ghorai SK; George C; Reith ME; Dutta AK
    J Med Chem; 2003 May; 46(11):2205-15. PubMed ID: 12747792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
    Rothman RB; Blough BE; Woolverton WL; Anderson KG; Negus SS; Mello NK; Roth BL; Baumann MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1361-9. PubMed ID: 15761112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and monoamine transporter binding of 2-(diarylmethoxymethyl)-3 beta-aryltropane derivatives.
    Xu L; Kulkarni SS; Izenwasser S; Katz JL; Kopajtic T; Lomenzo SA; Newman AH; Trudell ML
    J Med Chem; 2004 Mar; 47(7):1676-82. PubMed ID: 15027858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 4'-chloro-3 alpha-(diphenylmethoxy)-tropane on mesostriatal, mesocortical, and mesolimbic dopamine transmission: comparison with effects of cocaine.
    Tanda G; Ebbs A; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2005 May; 313(2):613-20. PubMed ID: 15681658
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinctions between dopamine transporter antagonists could be just around the bend.
    Henry LK; Blakely RD
    Mol Pharmacol; 2008 Mar; 73(3):616-8. PubMed ID: 18156312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of novel trisubstituted asymmetric derivatives of (2S,4R,5R)-2-benzhydryl-5-benzylaminotetrahydropyran-4-ol, exhibiting high affinity for serotonin and norepinephrine transporters in a stereospecific manner.
    Zhang S; Zhen J; Reith ME; Dutta AK
    J Med Chem; 2005 Jul; 48(15):4962-71. PubMed ID: 16033275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.
    Gorentla BK; Vaughan RA
    Neuropharmacology; 2005 Nov; 49(6):759-68. PubMed ID: 16181646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of environmental enrichment on behavior and dopamine transporter function in medial prefrontal cortex in adult rats prenatally treated with cocaine.
    Neugebauer NM; Cunningham ST; Zhu J; Bryant RI; Middleton LS; Dwoskin LP
    Brain Res Dev Brain Res; 2004 Nov; 153(2):213-23. PubMed ID: 15527889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinatorial synthesis of benztropine libraries and their evaluation as monoamine transporter inhibitors.
    Pedersen H; Sinning S; Bulow A; Wiborg O; Falborg L; Bols M
    Org Biomol Chem; 2004 Oct; 2(19):2861-9. PubMed ID: 15455161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population pharmacokinetics, brain distribution, and pharmacodynamics of 2nd generation dopamine transporter selective benztropine analogs developed as potential substitute therapeutics for treatment of cocaine abuse.
    Syed SA; Newman AH; Othman AA; Eddington ND
    J Pharm Sci; 2008 May; 97(5):1993-2007. PubMed ID: 17879975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine.
    Desai RI; Kopajtic TA; Koffarnus M; Newman AH; Katz JL
    J Neurosci; 2005 Feb; 25(8):1889-93. PubMed ID: 15728828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter.
    Reith ME; Berfield JL; Wang LC; Ferrer JV; Javitch JA
    J Biol Chem; 2001 Aug; 276(31):29012-8. PubMed ID: 11395483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interaction of cocaine-, benztropine-, and GBR12909-like compounds with wild-type and mutant human dopamine transporters: molecular features that differentially determine antagonist-binding properties.
    Schmitt KC; Zhen J; Kharkar P; Mishra M; Chen N; Dutta AK; Reith ME
    J Neurochem; 2008 Nov; 107(4):928-40. PubMed ID: 18786172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.
    Schmitt KC; Reith ME
    Ann N Y Acad Sci; 2010 Feb; 1187():316-40. PubMed ID: 20201860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.